Welo Life Sciences has unveiled Glass PV, an innovative translation platform designed to address the unique challenges of AI-enabled pharmacovigilance case translation. Launched on October 14, 2026, Glass PV significantly aids in translating scanned adverse event documents, allowing safety teams to meet stringent regulatory requirements without bottlenecking the process. This tool transforms the manual and often cumbersome process into a streamlined operation. Cristina Pardo, General Manager of Welo Life Sciences, emphasizes that teams are under pressure to translate complex documents rapidly, without the inefficiencies of multiple personnel and extensive email chains.

Glass PV is already a game changer, offering translation services in more than 300 languages. Pardo highlights the system's capability to deliver a near-perfect record of compliance with regulatory timeframes, achieving close to 100% of case translations within the mandated 12- or 24-hour windows. The automation embedded in Glass PV manages both data extraction and preservation of complex document layouts, enhancing speed and accuracy. Safety narratives, often crucial and detailed, are handled by linguists with expertise in the field, ensuring that the automated outputs align with industry standards. This integration of technology and human expertise underscores the platform's strong accountability measures, where every edit and decision is meticulously documented — a claim noted by GALA Global.

Pardo's approach signifies a shift towards a more seamless integration of automation and linguistic oversight in pharmacovigilance. The ability to reopen and review any translation ensures transparency and validates the quality of the output, aligning with regulatory scrutiny. By eliminating manual handoffs, safety teams can directly submit cases and receive translated documents with preserved layouts, demonstrating an efficiency that traditional methods lack. "We put our name on the clock and on the quality," asserts Pardo, a testament to the trust Welo Life Sciences places in Glass PV's performance and reliability. This endeavor not only complements the regulatory requirements but also exemplifies how cutting-edge technology can be harnessed to meet the evolving needs of the life sciences industry.